
FOOT & ANKLE
Efficacy of platelet-rich plasma injection for chronic plantar fasciopathy remains unknown
This report has been verified
by one or more authors of the
original publication.
Br Med Bull. 2014 Dec;112(1):83-95.
8 studies were included in this systematic review examining whether platelet-rich plasma (PRP) injections are an effective treatment for chronic plantar fasciopathy (PF). While 2 of the studies indicated no significant improvement when platelet-rich plasma injections were administered compared to either corticosteroids (CCS) injections or dextrose prolotherapy, the other 6 studies indicated that PRP may be an effective intervention based mainly on VAS and Roles and Maudsley scores. No complications were observed in patients receiving PRP injections. However, due to contradictory results, no definitive conclusion can be reached at this point regarding the effectiveness of PRP injections for the treatment of plantar fasciopathy. Further randomized trials using placebo control groups are needed to determine if this treatment is efficacious.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in


Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now